Abstract:Objective: Long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) are widely expressed in the brain and are associated with the development of neurological and neurodegenerative diseases. However, their roles and molecular mechanisms in major depressive disorder (MDD) remain largely unknown. This study aimed to identify lncRNAs and miRNAs involved in the development of MDD and elucidate their molecular mechanisms. Methods: Transcriptome and bioinformatic analyses were performed to identify miRNAs and lncRNAs related to MDD. C57 mice were subjected to chronic unpredictable mild stress (CUMS) to establish a depression model. Lentiviruses containing either lncRNA NPTN-IT1-201 or miR-142-5p were microinjected into the hippocampal region of these mice. Behavioral tests including the sucrose preference test (SPT), tail suspension test (TST), and forced swim test (FST) were conducted to evaluate depressive-like behaviors. Results: The results revealed that overexpression of lncRNA NPTN-IT1-201 or inhibition of miR-142-5p significantly ameliorated depressive-like behaviors in CUMS-treated mice. Dual-luciferase reporter assays confirmed interactions between miR-142-5p with both brain-derived neurotrophic factor (BDNF) and NPTN-IT1-201. ELISA analysis revealed significant alterations in relevant biomarkers in the blood samples of MDD patients compared to healthy controls. Histological analyses, including HE and Nissl staining, showed marked structural changes in brain tissues following CUMS treatment, which were partially reversed by lncRNA NPTN-IT1-201 overexpression or miR-142-5p inhibition. Immunofluorescence imaging demonstrated significant differences in the levels of BAX, Bcl2, p65, Iba1 among different treatment groups. TUNEL assays confirmed reduced apoptosis in brain tissues following these interventions. Western blotting showed the significant differences in BDNF, BAX, and Bcl2 protein levels among different treatment groups. Conclusion: NPTN-IT1-201 regulates inflammation and apoptosis in MDD by targeting BDNF via miR-142-5p, making it a potential therapeutic target for MDD.

Mir-143-3p Modulates Depressive-Like Behaviors Via Lasp1 in the Mouse Ventral Hippocampus.

Blood Mir-144-3p: a Novel Diagnostic and Therapeutic Tool for Depression

Mir-138 Increases Depressive-Like Behaviors by Targeting SIRT1 in Hippocampus

MiR-184-3p in the paraventricular nucleus participates in the neurobiology of depression via regulation of the hypothalamus-pituitary-adrenal axis

Mir-214-3p Targets Β-Catenin to Regulate Depressive-like Behaviors Induced by Chronic Social Defeat Stress in Mice

Clinical and preclinical evaluation of miR-144-5p as a key target for major depressive disorder

miR-29a-5p rescues depressive-like behaviors in a CUMS-induced mouse model by facilitating microglia M2-polarization in the prefrontal cortex via TMEM33 suppression

lncRNA MIR155HG Alleviates Depression-Like Behaviors in Mice by Regulating the miR-155/BDNF Axis

miR-34a induces spine damages via inhibiting synaptotagmin-1 in depression

MicroRNA-26a-3p rescues depression-like behaviors in male rats via preventing hippocampal neuronal anomalies

Hippocampal miR-211-5p regulates neurogenesis and depression-like behaviors in the rat

MicroRNA-451a is a candidate biomarker and therapeutic target for major depressive disorder

MiR-182-5p: A Novel Biomarker in the Treatment of Depression in CSDS-Induced Mice

Mir-16 and Fluoxetine Both Reverse Autophagic and Apoptotic Change in Chronic Unpredictable Mild Stress Model Rats.

MicroRNA-204-5p reduction in rat hippocampus contributes to stress-induced pathology via targeting RGS12 signaling pathway

LncRNA NPTN-IT1-201 Ameliorates Depressive-like Behavior by Targeting miR-142-5p and Regulating Inflammation and Apoptosis via BDNF

MicroRNA-101 in the Ventrolateral Orbital Cortex (VLO) Modulates Depressive-Like Behaviors in Rats and Targets Dual-Specificity Phosphatase 1 (DUSP1)

MiR-139-5p has an antidepressant-like effect by targeting phosphodiesterase 4D to activate the cAMP/PKA/CREB signaling pathway

Knockdown of Mir-124 Reduces Depression-like Behavior by Targeting CREB1 and BDNF.

Hippocampal miR-206-3p participates in the pathogenesis of depression via regulating the expression of BDNF

Increased Expression of a Novel Mirna in Peripheral Blood is Negatively Correlated with Hippocampal Volume in Patients with Major Depressive Disorder.